Japanese society for dialysis therapy renal data registry—a window through which we can view the details of Japanese dialysis population
暂无分享,去创建一个
Norio Hanafusa | K. Iseki | S. Nakai | N. Hanafusa | Kunitoshi Iseki | Shigeru Nakai | Yoshiharu Tsubakihara | Y. Tsubakihara
[1] Takayuki Hamano,et al. Overview of Regular Dialysis Treatment in Japan (as of 31 December 2011) , 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[2] K. Kikuchi,et al. Prevalence and Determinants of Hypertension in Chronic Hemodialysis Patients in Japan , 2007, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[3] CaCO,et al. Clinical Practice Guideline for the Management of Secondary Hyperparathyroidism in Chronic Dialysis Patients , 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[4] K. Iseki,et al. A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[5] Takashi Satou,et al. 2011 update Japanese Society for Dialysis Therapy Guidelines of Vascular Access Construction and Repair for Chronic Hemodialysis , 2006, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[6] N. Izumi,et al. 2011 Japanese Society for Dialysis Therapy Guidelines for the Treatment of Hepatitis C Virus Infection in Dialysis Patients , 2012, Therapeutic apheresis and dialysis.
[7] K. Iseki,et al. Increased risk of hip fracture among Japanese hemodialysis patients , 2013, Journal of Bone and Mineral Metabolism.
[9] K. Iseki,et al. Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder , 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[10] N. Fujii,et al. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. , 2014, Kidney international.
[11] H. Hirakata,et al. Standard on Microbiological Management of Fluids for Hemodialysis and Related Therapies by the Japanese Society for Dialysis Therapy 2008 , 2009, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[12] K. Iseki,et al. Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[13] S. Nakai,et al. Nephrology Dialysis Transplantation Survival in Long-term Haemodialysis Patients: Results from the Annual Survey of the Japanese Society for Dialysis Therapy , 2022 .
[14] K. Iseki,et al. Regional Variation in Hip Fracture Incidence Among Japanese Hemodialysis Patients , 2014, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[15] H. Hirakata,et al. 2011 JSDT Standard on the Management of Endotoxin Retentive Filter for Dialysis and Related Therapies , 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[16] H. Haruguchi,et al. 2005 Japanese Society for Dialysis Therapy Guidelines for Vascular Access Construction and Repair for Chronic Hemodialysis , 2006, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[17] K. Iseki,et al. Effects of Serum Calcium, Phosphorous, and Intact Parathyroid Hormone Levels on Survival in Chronic Hemodialysis Patients in Japan , 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[18] K. Iseki,et al. Ideal Timing and Predialysis Nephrology Care Duration for Dialysis Initiation: From Analysis of Japanese Dialysis Initiation Survey , 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[19] K. Wakai,et al. Factors associated with the incidence of dialysis , 2013, Clinical and Experimental Nephrology.
[20] K. Iseki,et al. Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis Patients , 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[21] W. März,et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005, The New England journal of medicine.
[22] K. Fushimi,et al. An Overview of Dialysis Treatment in Japan. , 2001 .
[23] K. Iseki,et al. 2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease , 2010, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[24] K. Iseki,et al. Carpal Tunnel Surgery as Proxy for Dialysis-Related Amyloidosis: Results from the Japanese Society for Dialysis Therapy , 2014, American Journal of Nephrology.
[25] K. Iseki,et al. Increasing Gender Difference in the Incidence of Chronic Dialysis Therapy in Japan , 2005, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[26] K. Iseki,et al. Higher Survival Rates of Chronic Hemodialysis Patients on Anti-Hypertensive Drugs , 2009, Nephron Clinical Practice.
[27] H. Hirakata,et al. 2004 Japanese Society for Dialysis Therapy Guidelines for Renal Anemia in Chronic Hemodialysis Patients * , 2004, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[28] H. Hirakata,et al. Japanese Society for Dialysis Therapy Guidelines for Management of Cardiovascular Diseases in Patients on Chronic Hemodialysis , 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[29] Gert Mayer,et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. , 2009, The New England journal of medicine.
[30] K. Iseki,et al. Bacteriological Qualities of Dialysis Fluid in Japan as of 31 December 2006 , 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[31] S. Fukuhara,et al. Erythropoiesis-stimulating agent responsiveness and mortality in hemodialysis patients: results from a cohort study from the dialysis registry in Japan. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[32] K. Iseki,et al. Tachycardia as a predictor of poor survival in chronic haemodialysis patients. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] B. Kasiske,et al. US Renal Data System 2013 Annual Data Report. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[34] K. Iseki,et al. Bacteriological Water Quality in the Central Dialysis Fluid Delivery System from the Survey of the Japanese Society for Dialysis Therapy , 2009, Blood Purification.
[35] K. Kikuchi,et al. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.